A subsequent study reported that the combination of cetuximab and IL-15 further activated tumor killing by NK cells and stimulated the maturation of dendritic cells (DCs) in a co-culture experiment with the TNBC cell line IIB-BR-G [439]. This evidence concerns the gene IL15 and neoplasm.